These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5918592)

  • 1. Influence of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999) on ventricular fibrillation induced by coronary occlusion.
    Kaumann AJ; Aramendia P
    Acta Physiol Lat Am; 1966; 16(2):206-7. PubMed ID: 5918592
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic activity of the dextro- and levorotatory isomers of 4-(2-isopropylamino-1-hydroxyethyl) methanesulfonanilide (MJ 1999).
    Somani P; Watson DL
    J Pharmacol Exp Ther; 1968 Dec; 164(2):317-25. PubMed ID: 5699093
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonism of epinephrine-induced cardiac arrhythmias by 4-(2-isopropylamino-1-hydroxyethyl)-methanesulfonanilide (MJ 1999) .
    Somani P; Fleming JG; Chan GK; Lum BK
    J Pharmacol Exp Ther; 1966 Jan; 151(1):32-7. PubMed ID: 5902176
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of cicletanine on a sudden death model in dogs].
    Guillon JM; Thievant P; Braquet P
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():151-4. PubMed ID: 2514657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of p-tyrosol on myocardial electric instability induced by coronary occlusion].
    Chernyshov GA; Plotnikov MB; Smol'iakova VI; Krasnov EA
    Eksp Klin Farmakol; 2007; 70(4):23-5. PubMed ID: 18078037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The antifibrillatory properties of bonnecor].
    Grigor'eva EK; Gorbunova VV
    Farmakol Toksikol; 1990; 53(3):36-7. PubMed ID: 2387377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.
    Singh BN; Vaughan Williams EM
    Br J Pharmacol; 1970 Aug; 39(4):675-87. PubMed ID: 5485144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular fibrillation after acute coronary artery occlusion. An experimental study.
    Pifarré R; Yokoyama T; Ilano AC; Hufnagel CA
    J Thorac Cardiovasc Surg; 1967 Mar; 53(3):335-40. PubMed ID: 6019145
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparative study of different classes of anti-arrhythmia agents on the vulnerability of ischemic ventricular fibrillation].
    Aupetit JF; Timour Q; Chevrel G; Omar S; Loufoua-Moundanga J; Faucon G
    Therapie; 1993; 48(4):403-7. PubMed ID: 8128424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacologic treatment for ventricular arrhythmias].
    Halawa B
    Pol Merkur Lekarski; 1997 Aug; 3(14):45-9. PubMed ID: 9480172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on the genesis of ventricular fibrillation in the course of a temporary occlusion of the coronary artery. II.
    Wojtowicz M; Dybicki J; Zawistowski S; Wrzolek S; Bartoszewicz T
    Pol Med J; 1967; 6(2):479-81. PubMed ID: 6030655
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of diltiazem upon experimental ventricular dysrhythmias.
    Patterson E; Eller BT; Lucchesi BR
    J Pharmacol Exp Ther; 1983 Apr; 225(1):224-33. PubMed ID: 6834274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological profile of a new anti-arrhythmia agent: bunaftide].
    Beani L
    Boll Soc Ital Cardiol; 1972; 17(12):1279-81. PubMed ID: 4681455
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prognosis and management of patients with tachycardial heart arrhythmia ].
    Steinbach K
    Wien Med Wochenschr; 1984 Oct; 134(19-20):425-6. PubMed ID: 6516418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term management of the survivor of ventricular fibrillation or sustained ventricular tachycardia.
    Connolly SJ; Krahn A; Klein G
    Can J Cardiol; 2000 Jun; 16 Suppl C():20C-2C. PubMed ID: 10887273
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in antiarrhythmic drug therapy--changing concepts. Introduction.
    Kaplan HR
    Fed Proc; 1986 Jul; 45(8):2184-5. PubMed ID: 3720961
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of dauricine combined with other anti-arrhythmia agents on electrically induced ventricular fibrillation in rabbits].
    Du ZH; Liu HG; Zeng FD; Hu CJ
    Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):33-6. PubMed ID: 3188931
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
    Gülker H; Thale J; Brisse B; Bender F
    Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
    Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.